Results 161 to 170 of about 24,384 (198)

Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8⁺ T cell activity and Fcγ receptor-mediated modulation of the tumor microenvironment. [PDF]

J Immunother Cancer
Son W, Lee Y, Park Y, Park KS, Kim S, Youn H, Seo A, Sung B, Lee SH, Won J.   +9 more
europepmc   +1 more source

IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages. [PDF]

Cell Death Dis
Zhang J, Dong Y, Yu S, Hu K, Zhang L, Xiong M, Liu M, Sun X, Li S, Yuan Y, Zhang C, Zhu M, Wei Y, Zhu Y, Yu Y, Zhang P, Liu T.   +16 more
europepmc   +1 more source

Boosting with adjuvanted SCB-2019 elicits superior Fcγ-receptor engagement driven by IgG3 to SARS-CoV-2 spike. [PDF]

NPJ Vaccines
Jung W, Yuan D, Kellman B, Gonzalez IGDS, Clemens R, Milan EP, Sprinz E, Cerbino Neto J, Smolenov I, Alter G, McNamara RP, Costa Clemens SA.   +11 more
europepmc   +1 more source

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2

, 2022
Mackin SR, Desai P, Whitener BM, Karl CE, Liu M, Baric RS, Edwards DK, Chicz TM, McNamara RP, Alter G, Diamond MS.   +10 more
europepmc   +1 more source

GWAS for systemic sclerosis identifies six novel susceptibility loci including one in the Fcγ receptor region. [PDF]

Nat Commun
Ishikawa Y, Tanaka N, Asano Y, Kodera M, Shirai Y, Akahoshi M, Hasegawa M, Matsushita T, Saito K, Motegi SI, Yoshifuji H, Yoshizaki A, Kohmoto T, Takagi K, Oka A, Kanda M, Tanaka Y, Ito Y, Nakano K, Kasamatsu H, Utsunomiya A, Sekiguchi A, Niiro H, Jinnin M, Makino K, Makino T, Ihn H, Yamamoto M, Suzuki C, Takahashi H, Nishida E, Morita A, Yamamoto T, Fujimoto M, Kondo Y, Goto D, Sumida T, Ayuzawa N, Yanagida H, Horita T, Atsumi T, Endo H, Shima Y, Kumanogoh A, Hirata J, Otomo N, Suetsugu H, Koike Y, Tomizuka K, Yoshino S, Liu X, Ito S, Hikino K, Suzuki A, Momozawa Y, Ikegawa S, Tanaka Y, Ishikawa O, Takehara K, Torii T, Sato S, Okada Y, Mimori T, Matsuda F, Matsuda K, Amariuta T, Imoto I, Matsuo K, Kuwana M, Kawaguchi Y, Ohmura K, Terao C.   +71 more
europepmc   +1 more source

Dysregulated Fcγ receptor IIa-induced cytokine production in dendritic cells of lupus nephritis patients. [PDF]

Clin Exp Immunol, 2020
Newling M, Fiechter RH, Sritharan L, Hoepel W, van Burgsteden JA, Hak AE, van Vollenhoven RF, van de Sande MGH, Baeten DLP, den Dunnen J.   +9 more
europepmc   +1 more source

Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions. [PDF]

Sci Rep, 2017
Qureshi OS, Rowley TF, Junker F, Peters SJ, Crilly S, Compson J, Eddleston A, Björkelund H, Greenslade K, Parkinson M, Davies NL, Griffin R, Pither TL, Cain K, Christodoulou L, Staelens L, Ward E, Tibbitts J, Kiessling A, Smith B, Brennan FR, Malmqvist M, Fallah-Arani F, Humphreys DP.   +23 more
europepmc   +1 more source

Adeno-associated virus-vectored influenza vaccine elicits neutralizing and Fcγ receptor-activating antibodies. [PDF]

EMBO Mol Med, 2020
Demminger DE, Walz L, Dietert K, Hoffmann H, Planz O, Gruber AD, von Messling V, Wolff T.   +7 more
europepmc   +1 more source

Blocking HIV-1 replication: are Fc-Fcγ receptor interactions required? [PDF]

J Clin Invest, 2019
Forthal D, Finzi A.
europepmc   +1 more source

Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model. [PDF]

Cancer Immunol Immunother, 2019
Kasahara Y, Shirota H, Umegaki S, Ishioka C.   +3 more
europepmc   +1 more source